Adprotech Ltd. acquired by Inflazyme Pharmaceuticals Inc.
5600 Parkwood Way. Suite 425 Richmond British Columbia V6V 2M2 Canada
+1-604-279-8511
+1-604-279-8711
inflammation technology platform; complement inhibition and a potential novel clinical compound being developed for the treatment of rheumatoid arthritis